Advanced in Telangiectasia

Michael J. Kutryk

St. Michael's Hospital, 
Toronto, ON, CA 
Advanced in Telangiectasia
St. Michael's Hospital, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Michael Kutryk practices in Toronto, Canada. Mr. Kutryk is rated as an Advanced expert by MediFind in the treatment of Telangiectasia. His top areas of expertise are Hereditary Hemorrhagic Telangiectasia, Telangiectasia, Congenital Coronary Artery Malformation, and Heart Attack.

His clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Telangiectasia.

Gender
Male

Locations

St. Michael's Hospital, Toronto, ON, Canada
Other Locations
St Michael's Hospital Toronto, Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
A Phase IIb, Randomized, Double-blind, Placebo Controlled Study Using Transplantation of Autologous Early Endothelial Progenitor Cells(EPCs) for Patients Who Have Suffered Acute Myocardial Infarction
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Biological
Study Drugs: Plasma-Lyte A and Autologous Plasma, Autologous EPCs, Autologous EPCs Transfected with human eNOS
Study Phase: Phase 2

27 Total Publications

Overexpression of miR-454-3p inhibits high glucose-induced ET-1 expression, leading to eNOS upregulation in endothelial cells: an integrated bioinformatics and experimental analysis.
Overexpression of miR-454-3p inhibits high glucose-induced ET-1 expression, leading to eNOS upregulation in endothelial cells: an integrated bioinformatics and experimental analysis.
Journal: Human cell
Published: August 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kutryk's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile